Asian Spectator

Men's Weekly

.

Shineway Pharmaceutical (2877.HK) recorded 29.4% revenue growth for October 2020

  • Written by ACN Newswire - Press Releases

Shineway Pharmaceutical (2877.HK) recorded 29.4% revenue growth for October 2020

HONG KONG, Nov 30, 2020 - (ACN Newswire) - Shineway Pharmaceutical (stock code: 2877.HK) recorded 29.4% revenue growth for October 2020 in comparison with the same period last year, as sales of injection products, soft capsule products, granule products, TCM formula granules, and other dosage forms went up 38.9%, 17.4%, 38.1%, 7.9% and 54.0% respectively.

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

How Does A Commercial Electrician Ensure Your Business Stays Powered Safely?

Running a business, regardless of its size or industry, comes with a myriad of responsibilities. Among the most critical is ensuring a safe and reliable electrical system. Unlike residential propert...

Melawan taktik baru ‘pre-order’ produk Ramadan-Idulfitri dengan adab belanja khas Islam

● Konsumsi masyarakat di bulan Ramadan 2025 berpotensi terus bertumbuh.● Sejak awal tahun, para penjual sudah marak menjajakan dagangannya di platform ‘online’.● Tekanan ...

Dari ‘Bridgerton’ hingga ‘Heated Rivalry’, apa resep sukses adaptasi buku ke TV?

HBO/Netflix/The ConversationDi luar judul-judul klasik seperti Pride and Prejudice, fiksi roman secara historis jarang dilirik untuk diadaptasi ke layar lebar maupun televisi, meskipun popularitasnya ...